Back
Top 2%
23.5%
Top 26%
23.5%
Top 18%
8.2%
Top 2%
6.8%
Top 5%
5.3%
Top 0.4%
4.1%
Top 14%
2.0%
Top 15%
2.0%
Top 4%
2.0%
Top 46%
1.4%
Top 19%
1.4%
#1
1.4%
Top 17%
1.2%
Top 25%
1.2%
Top 52%
0.8%
Top 22%
0.8%
Top 14%
0.8%
Top 3%
0.5%
Predictors of non-participation in azithromycin mass drug administration to reduce mortality among children 1-11 months old in Niger: a coverage evaluation survey
2026-02-06
public and global health
Title + abstract only
View on medRxiv
Show abstract
The World Health Organization recommends biannual azithromycin mass drug administration (MDA) to infants aged 1-11 months to reduce mortality, following promising results from trials in West Africa. High coverage seen in well-resourced trials may decline as the intervention transitions to a real-world program. As a result, the most vulnerable children facing the highest risk of mortality may be missed. We aimed to identify predictors of non-participation in an azithromycin MDA program to inform ...
Predicted journal destinations
1
PLOS Global Public Health
287 training papers
2
PLOS ONE
1737 training papers
3
BMJ Open
553 training papers
4
BMJ Global Health
95 training papers
5
PLOS Neglected Tropical Diseases
166 training papers
6
The American Journal of Tropical Medicine and Hygiene
50 training papers
7
Clinical Infectious Diseases
219 training papers
8
BMC Public Health
148 training papers
9
Vaccine
140 training papers
10
Nature Communications
483 training papers
11
BMC Medicine
155 training papers
12
Tropical Medicine & International Health
15 training papers
13
BMC Infectious Diseases
110 training papers
14
Frontiers in Public Health
135 training papers
15
eLife
262 training papers
16
PLOS Medicine
95 training papers
17
Vaccines
131 training papers
18
The Lancet Global Health
24 training papers